Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: J Neuroimmunol. 2011 Mar 11;234(1-2):131–140. doi: 10.1016/j.jneuroim.2011.02.001

Figure 3. Cumulative TCRBV usage in MBP-specific T-cells.

Figure 3

These graphs represent cumulative data from Figure 3, depicting overall TCR usage among MBP-specific CD4+ (A) and CD8+ (B) T-cells from healthy subjects vs. MS patients (*p<0.08; **p<0.05).